84 related articles for article (PubMed ID: 8895513)
1. The role of p53 in the induction of polyploidity of myelomonocytic leukemic M1/2 cells.
Peled A; Schwartz D; Elkind NB; Wolkowicz R; Li R; Rotter V
Oncogene; 1996 Oct; 13(8):1677-85. PubMed ID: 8895513
[TBL] [Abstract][Full Text] [Related]
2. Mutant p53 protein expression interferes with p53-independent apoptotic pathways.
Li R; Sutphin PD; Schwartz D; Matas D; Almog N; Wolkowicz R; Goldfinger N; Pei H; Prokocimer M; Rotter V
Oncogene; 1998 Jun; 16(25):3269-77. PubMed ID: 9681825
[TBL] [Abstract][Full Text] [Related]
3. p53 involvement in control of G2 exit of the cell cycle: role in DNA damage-induced apoptosis.
Guillouf C; Rosselli F; Krishnaraju K; Moustacchi E; Hoffman B; Liebermann DA
Oncogene; 1995 Jun; 10(11):2263-70. PubMed ID: 7784074
[TBL] [Abstract][Full Text] [Related]
4. Expression of wild-type p53 increases etoposide cytotoxicity in M1 myeloid leukemia cells by facilitated G2 to M transition: implications for gene therapy.
Skladanowski A; Larsen AK
Cancer Res; 1997 Mar; 57(5):818-23. PubMed ID: 9041178
[TBL] [Abstract][Full Text] [Related]
5. Alterations in tumor development in vivo mediated by expression of wild type or mutant p53 proteins.
Shaulsky G; Goldfinger N; Rotter V
Cancer Res; 1991 Oct; 51(19):5232-7. PubMed ID: 1717142
[TBL] [Abstract][Full Text] [Related]
6. p53 is a regulator of macrophage differentiation.
Matas D; Milyavsky M; Shats I; Nissim L; Goldfinger N; Rotter V
Cell Death Differ; 2004 Apr; 11(4):458-67. PubMed ID: 14713961
[TBL] [Abstract][Full Text] [Related]
7. [Establishment and characterization of rat myelomonocytic leukemia clones undergoing differentiation or apoptosis].
Yoshida H
Hokkaido Igaku Zasshi; 2000 Nov; 75(6):375-84. PubMed ID: 11193930
[TBL] [Abstract][Full Text] [Related]
8. Role of p53 in G2/M cell cycle arrest and apoptosis in response to gamma-irradiation in ovarian carcinoma cell lines.
Concin N; Stimpfl M; Zeillinger C; Wolff U; Hefler L; Sedlak J; Leodolter S; Zeillinger R
Int J Oncol; 2003 Jan; 22(1):51-7. PubMed ID: 12469184
[TBL] [Abstract][Full Text] [Related]
9. Mutant human tumor suppressor p53 modulates the activation of mitogen-activated protein kinase and nuclear factor-kappaB, but not c-Jun N-terminal kinase and activated protein-1.
Gulati AP; Yang YM; Harter D; Mukhopadhyay A; Aggarwal BB; Benzil DL; Whysner J; Albino AP; Murali R; Jhanwar-Uniyal M
Mol Carcinog; 2006 Jan; 45(1):26-37. PubMed ID: 16267831
[TBL] [Abstract][Full Text] [Related]
10. Cytotoxic effects of adenovirus-mediated wild-type p53 protein expression in normal and tumor mammary epithelial cells.
Katayose D; Gudas J; Nguyen H; Srivastava S; Cowan KH; Seth P
Clin Cancer Res; 1995 Aug; 1(8):889-97. PubMed ID: 9816059
[TBL] [Abstract][Full Text] [Related]
11. p53/p21(CIP1) cooperate in enforcing rapamycin-induced G(1) arrest and determine the cellular response to rapamycin.
Huang S; Liu LN; Hosoi H; Dilling MB; Shikata T; Houghton PJ
Cancer Res; 2001 Apr; 61(8):3373-81. PubMed ID: 11309295
[TBL] [Abstract][Full Text] [Related]
12. Induction of Fas expression and augmentation of Fas/Fas ligand-mediated apoptosis by the synthetic retinoid CD437 in human lung cancer cells.
Sun SY; Yue P; Hong WK; Lotan R
Cancer Res; 2000 Nov; 60(22):6537-43. PubMed ID: 11103825
[TBL] [Abstract][Full Text] [Related]
13. Loss of p53 tumor suppressor function is required for in vivo progression of Friend erythroleukemia.
Prasher JM; Elenitoba-Johnson KS; Kelley LL
Oncogene; 2001 May; 20(23):2946-55. PubMed ID: 11420707
[TBL] [Abstract][Full Text] [Related]
14. p53-associated 3'-->5' exonuclease activity in nuclear and cytoplasmic compartments of cells.
Lilling G; Elena N; Sidi Y; Bakhanashvili M
Oncogene; 2003 Jan; 22(2):233-45. PubMed ID: 12527892
[TBL] [Abstract][Full Text] [Related]
15. Role of wild type p53 in the G2 phase: regulation of the gamma-irradiation-induced delay and DNA repair.
Schwartz D; Almog N; Peled A; Goldfinger N; Rotter V
Oncogene; 1997 Nov; 15(21):2597-607. PubMed ID: 9399647
[TBL] [Abstract][Full Text] [Related]
16. Role of p53 in the regulation of irradiation-induced apoptosis in neuroblastoma cells.
Jasty R; Lu J; Irwin T; Suchard S; Clarke MF; Castle VP
Mol Genet Metab; 1998 Oct; 65(2):155-64. PubMed ID: 9787107
[TBL] [Abstract][Full Text] [Related]
17. [The effect of the tumor suppressor p53 and its mutant forms on the differentiation and viability of K562 leukemic cells].
Kremenetskaia OS; Logacheva NP; Baryshnikov AIu; Chumakov PM; Kopnin BP
Tsitologiia; 1996; 38(12):1280-93. PubMed ID: 9163103
[TBL] [Abstract][Full Text] [Related]
18. p53-dependent p21 induction following gamma-irradiation without concomitant p53 induction in a human peripheral neuroepithelioma cell line.
Isaacs JS; Chiao C; Merrick BA; Selkirk JK; Barrett JC; Weissman BE
Cancer Res; 1997 Jul; 57(14):2986-92. PubMed ID: 9230213
[TBL] [Abstract][Full Text] [Related]
19. Wild-type p53 reduces radiation hypermutability in p53-mutated human lymphoblast cells.
Zhang Q; Liu Y; Zhou J; Chen W; Zhang Y; Liber HL
Mutagenesis; 2007 Sep; 22(5):329-34. PubMed ID: 17567629
[TBL] [Abstract][Full Text] [Related]
20. Response of Ewing tumor cells to forced and activated p53 expression.
Kovar H; Pospisilova S; Jug G; Printz D; Gadner H
Oncogene; 2003 May; 22(21):3193-204. PubMed ID: 12761489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
